Vericel (VCEL) Times Interest Earned (2010 - 2026)
Vericel (VCEL) posted Times Interest Earned of $0.69 for Q2 2026, up 105.38% sequentially from -$12.9 in Q1 2026, and up 121.39% YoY from $0.31 in Q2 2025.
Powered by 
Analysis
Vericel (VCEL) Times Interest Earned (2010 - 2026) Analysis & Trends
Vericel has reported Times Interest Earned for 17 years, with the latest figure at $0.69 in Q2 2026.
- Quarterly Times Interest Earned rose 121.39% year-over-year to $0.69 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $29.18 (up 1428.5% YoY) and the FY2025 annual result came in at $0.27, up 714.92% from the prior year.
- Times Interest Earned advanced to $0.69 in Q2 2026 per VCEL's latest filing, from -$12.9 in the prior quarter.
- Over five years, Times Interest Earned peaked at $81.61 in Q4 2023 and troughed at -$454.1 in Q2 2022.
- A 5-year average of -$46.45 and a median of -$3.6 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned tumbled 25726.97% in 2024, then soared 239.96% in 2025.
- Over 5 years, Times Interest Earned stood at $27.29 in 2022, then jumped by 199.08% to $81.61 in 2023, then sank by 73.04% to $22.0 in 2024, then decreased by 1.27% to $21.72 in 2025, then sank by 96.8% to $0.69 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.69, -$12.9, and $21.72 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 2.71 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 |
| Mar 31, 2026 | -50.40 |
| Dec 31, 2025 | 138.36 |
| Sep 30, 2025 | 21.84 |
| Jun 30, 2025 | -12.92 |
| Mar 31, 2025 | -83.61 |
| Dec 31, 2024 | 119.99 |
| Sep 30, 2024 | -16.01 |
| Jun 30, 2024 | -39.42 |
| Mar 31, 2024 | -35.71 |
| Dec 31, 2023 | 81.61 |
| Sep 30, 2023 | -33.71 |
| Jun 30, 2023 | -40.01 |
| Mar 31, 2023 | -56.39 |
| Dec 31, 2022 | 27.29 |
| Sep 30, 2022 | -64.65 |
| Jun 30, 2022 | -454.10 |
| Mar 31, 2022 | -404.06 |
| Dec 31, 2021 | 4,141.00 |
| Sep 30, 2021 | -4,961.00 |